nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—PGR—multiple sclerosis	0.417	1	CbGaD
Etonogestrel—PGR—Betamethasone—multiple sclerosis	0.126	0.44	CbGbCtD
Etonogestrel—PGR—Dexamethasone—multiple sclerosis	0.0731	0.256	CbGbCtD
Etonogestrel—Danazol—Prednisone—multiple sclerosis	0.0685	0.33	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisone—multiple sclerosis	0.0489	0.236	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisolone—multiple sclerosis	0.0477	0.23	CrCrCtD
Etonogestrel—Testosterone—Prednisolone—multiple sclerosis	0.0425	0.205	CrCrCtD
Etonogestrel—CYP3A4—Fingolimod—multiple sclerosis	0.0214	0.0748	CbGbCtD
Etonogestrel—CYP3A4—Methylprednisolone—multiple sclerosis	0.0138	0.0482	CbGbCtD
Etonogestrel—CYP3A4—Triamcinolone—multiple sclerosis	0.0104	0.0365	CbGbCtD
Etonogestrel—CYP3A4—Mitoxantrone—multiple sclerosis	0.01	0.0352	CbGbCtD
Etonogestrel—CYP3A4—Betamethasone—multiple sclerosis	0.00895	0.0313	CbGbCtD
Etonogestrel—CYP3A4—Prednisolone—multiple sclerosis	0.00883	0.0309	CbGbCtD
Etonogestrel—CYP3A4—Prednisone—multiple sclerosis	0.00834	0.0292	CbGbCtD
Etonogestrel—CYP3A4—Dexamethasone—multiple sclerosis	0.00521	0.0182	CbGbCtD
Etonogestrel—Norelgestromin—PGR—multiple sclerosis	0.000628	0.182	CrCbGaD
Etonogestrel—Desogestrel—PGR—multiple sclerosis	0.000604	0.175	CrCbGaD
Etonogestrel—Norgestimate—PGR—multiple sclerosis	0.000565	0.164	CrCbGaD
Etonogestrel—Danazol—CCL2—multiple sclerosis	0.000517	0.15	CrCbGaD
Etonogestrel—Levonorgestrel—PGR—multiple sclerosis	0.000346	0.1	CrCbGaD
Etonogestrel—Danazol—PGR—multiple sclerosis	0.000315	0.0913	CrCbGaD
Etonogestrel—Norethindrone—PGR—multiple sclerosis	0.00028	0.0812	CrCbGaD
Etonogestrel—Convulsion—Methylprednisolone—multiple sclerosis	8.64e-05	0.00103	CcSEcCtD
Etonogestrel—Hypertension—Triamcinolone—multiple sclerosis	8.63e-05	0.00102	CcSEcCtD
Etonogestrel—Hypertension—Methylprednisolone—multiple sclerosis	8.61e-05	0.00102	CcSEcCtD
Etonogestrel—Urticaria—Mitoxantrone—multiple sclerosis	8.59e-05	0.00102	CcSEcCtD
Etonogestrel—Abdominal pain—Mitoxantrone—multiple sclerosis	8.55e-05	0.00101	CcSEcCtD
Etonogestrel—Body temperature increased—Mitoxantrone—multiple sclerosis	8.55e-05	0.00101	CcSEcCtD
Etonogestrel—Myalgia—Triamcinolone—multiple sclerosis	8.51e-05	0.00101	CcSEcCtD
Etonogestrel—Vomiting—Azathioprine—multiple sclerosis	8.5e-05	0.00101	CcSEcCtD
Etonogestrel—Arthralgia—Methylprednisolone—multiple sclerosis	8.49e-05	0.00101	CcSEcCtD
Etonogestrel—Myalgia—Methylprednisolone—multiple sclerosis	8.49e-05	0.00101	CcSEcCtD
Etonogestrel—Eye disorder—Prednisone—multiple sclerosis	8.48e-05	0.00101	CcSEcCtD
Etonogestrel—Anxiety—Methylprednisolone—multiple sclerosis	8.46e-05	0.001	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—multiple sclerosis	8.45e-05	0.001	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—multiple sclerosis	8.45e-05	0.001	CcSEcCtD
Etonogestrel—Rash—Azathioprine—multiple sclerosis	8.43e-05	0.001	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	8.43e-05	0.001	CcSEcCtD
Etonogestrel—Dermatitis—Azathioprine—multiple sclerosis	8.43e-05	0.001	CcSEcCtD
Etonogestrel—Depression—Methotrexate—multiple sclerosis	8.42e-05	0.001	CcSEcCtD
Etonogestrel—Ill-defined disorder—Dexamethasone—multiple sclerosis	8.42e-05	0.000999	CcSEcCtD
Etonogestrel—Ill-defined disorder—Betamethasone—multiple sclerosis	8.42e-05	0.000999	CcSEcCtD
Etonogestrel—Discomfort—Triamcinolone—multiple sclerosis	8.41e-05	0.000998	CcSEcCtD
Etonogestrel—Discomfort—Methylprednisolone—multiple sclerosis	8.39e-05	0.000996	CcSEcCtD
Etonogestrel—Headache—Azathioprine—multiple sclerosis	8.38e-05	0.000995	CcSEcCtD
Etonogestrel—Angioedema—Betamethasone—multiple sclerosis	8.29e-05	0.000984	CcSEcCtD
Etonogestrel—Angioedema—Dexamethasone—multiple sclerosis	8.29e-05	0.000984	CcSEcCtD
Etonogestrel—Angiopathy—Prednisone—multiple sclerosis	8.23e-05	0.000977	CcSEcCtD
Etonogestrel—Immune system disorder—Prednisone—multiple sclerosis	8.2e-05	0.000973	CcSEcCtD
Etonogestrel—Malaise—Betamethasone—multiple sclerosis	8.18e-05	0.000971	CcSEcCtD
Etonogestrel—Malaise—Dexamethasone—multiple sclerosis	8.18e-05	0.000971	CcSEcCtD
Etonogestrel—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.16e-05	0.000969	CcSEcCtD
Etonogestrel—Oedema—Triamcinolone—multiple sclerosis	8.16e-05	0.000969	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.14e-05	0.000966	CcSEcCtD
Etonogestrel—Infection—Triamcinolone—multiple sclerosis	8.1e-05	0.000962	CcSEcCtD
Etonogestrel—Infection—Methylprednisolone—multiple sclerosis	8.09e-05	0.00096	CcSEcCtD
Etonogestrel—Insomnia—Prednisolone—multiple sclerosis	8.02e-05	0.000953	CcSEcCtD
Etonogestrel—Alopecia—Prednisone—multiple sclerosis	8.02e-05	0.000952	CcSEcCtD
Etonogestrel—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.98e-05	0.000948	CcSEcCtD
Etonogestrel—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.97e-05	0.000946	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisolone—multiple sclerosis	7.97e-05	0.000946	CcSEcCtD
Etonogestrel—Mental disorder—Prednisone—multiple sclerosis	7.95e-05	0.000944	CcSEcCtD
Etonogestrel—Nausea—Azathioprine—multiple sclerosis	7.94e-05	0.000943	CcSEcCtD
Etonogestrel—Skin disorder—Methylprednisolone—multiple sclerosis	7.91e-05	0.000939	CcSEcCtD
Etonogestrel—Erythema—Prednisone—multiple sclerosis	7.9e-05	0.000938	CcSEcCtD
Etonogestrel—Malnutrition—Prednisone—multiple sclerosis	7.9e-05	0.000938	CcSEcCtD
Etonogestrel—Norethindrone—ALB—multiple sclerosis	7.88e-05	0.0228	CrCbGaD
Etonogestrel—Convulsion—Dexamethasone—multiple sclerosis	7.86e-05	0.000933	CcSEcCtD
Etonogestrel—Convulsion—Betamethasone—multiple sclerosis	7.86e-05	0.000933	CcSEcCtD
Etonogestrel—Hypertension—Dexamethasone—multiple sclerosis	7.83e-05	0.00093	CcSEcCtD
Etonogestrel—Hypertension—Betamethasone—multiple sclerosis	7.83e-05	0.00093	CcSEcCtD
Etonogestrel—Asthenia—Mitoxantrone—multiple sclerosis	7.76e-05	0.000921	CcSEcCtD
Etonogestrel—Myalgia—Betamethasone—multiple sclerosis	7.72e-05	0.000917	CcSEcCtD
Etonogestrel—Myalgia—Dexamethasone—multiple sclerosis	7.72e-05	0.000917	CcSEcCtD
Etonogestrel—Anxiety—Betamethasone—multiple sclerosis	7.69e-05	0.000914	CcSEcCtD
Etonogestrel—Anxiety—Dexamethasone—multiple sclerosis	7.69e-05	0.000914	CcSEcCtD
Etonogestrel—Discomfort—Dexamethasone—multiple sclerosis	7.63e-05	0.000906	CcSEcCtD
Etonogestrel—Discomfort—Betamethasone—multiple sclerosis	7.63e-05	0.000906	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—multiple sclerosis	7.62e-05	0.000905	CcSEcCtD
Etonogestrel—Pain—Prednisolone—multiple sclerosis	7.59e-05	0.000901	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—multiple sclerosis	7.58e-05	0.0009	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—multiple sclerosis	7.53e-05	0.000893	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—multiple sclerosis	7.49e-05	0.000889	CcSEcCtD
Etonogestrel—Methyltestosterone—ALB—multiple sclerosis	7.48e-05	0.0217	CrCbGaD
Etonogestrel—Urethral disorder—Methotrexate—multiple sclerosis	7.43e-05	0.000882	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.43e-05	0.000882	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.42e-05	0.00088	CcSEcCtD
Etonogestrel—Oedema—Betamethasone—multiple sclerosis	7.4e-05	0.000879	CcSEcCtD
Etonogestrel—Anaphylactic shock—Betamethasone—multiple sclerosis	7.4e-05	0.000879	CcSEcCtD
Etonogestrel—Oedema—Dexamethasone—multiple sclerosis	7.4e-05	0.000879	CcSEcCtD
Etonogestrel—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.4e-05	0.000879	CcSEcCtD
Etonogestrel—Diarrhoea—Mitoxantrone—multiple sclerosis	7.4e-05	0.000878	CcSEcCtD
Etonogestrel—Insomnia—Triamcinolone—multiple sclerosis	7.38e-05	0.000876	CcSEcCtD
Etonogestrel—Insomnia—Methylprednisolone—multiple sclerosis	7.36e-05	0.000874	CcSEcCtD
Etonogestrel—Infection—Betamethasone—multiple sclerosis	7.35e-05	0.000873	CcSEcCtD
Etonogestrel—Infection—Dexamethasone—multiple sclerosis	7.35e-05	0.000873	CcSEcCtD
Etonogestrel—Ill-defined disorder—Prednisone—multiple sclerosis	7.33e-05	0.00087	CcSEcCtD
Etonogestrel—Paraesthesia—Triamcinolone—multiple sclerosis	7.33e-05	0.00087	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisolone—multiple sclerosis	7.31e-05	0.000868	CcSEcCtD
Etonogestrel—Paraesthesia—Methylprednisolone—multiple sclerosis	7.31e-05	0.000868	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—multiple sclerosis	7.31e-05	0.000868	CcSEcCtD
Etonogestrel—Nervous system disorder—Dexamethasone—multiple sclerosis	7.26e-05	0.000862	CcSEcCtD
Etonogestrel—Nervous system disorder—Betamethasone—multiple sclerosis	7.26e-05	0.000862	CcSEcCtD
Etonogestrel—Angioedema—Prednisone—multiple sclerosis	7.22e-05	0.000857	CcSEcCtD
Etonogestrel—Dyspepsia—Triamcinolone—multiple sclerosis	7.18e-05	0.000853	CcSEcCtD
Etonogestrel—Dyspepsia—Methylprednisolone—multiple sclerosis	7.16e-05	0.000851	CcSEcCtD
Etonogestrel—Malaise—Prednisone—multiple sclerosis	7.12e-05	0.000846	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—multiple sclerosis	7.09e-05	0.000841	CcSEcCtD
Etonogestrel—Anorexia—Betamethasone—multiple sclerosis	7.06e-05	0.000838	CcSEcCtD
Etonogestrel—Anorexia—Dexamethasone—multiple sclerosis	7.06e-05	0.000838	CcSEcCtD
Etonogestrel—Urticaria—Prednisolone—multiple sclerosis	7.05e-05	0.000837	CcSEcCtD
Etonogestrel—Fatigue—Triamcinolone—multiple sclerosis	7.03e-05	0.000835	CcSEcCtD
Etonogestrel—Fatigue—Methylprednisolone—multiple sclerosis	7.02e-05	0.000833	CcSEcCtD
Etonogestrel—Pain—Triamcinolone—multiple sclerosis	6.98e-05	0.000828	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—multiple sclerosis	6.88e-05	0.000817	CcSEcCtD
Etonogestrel—Vomiting—Mitoxantrone—multiple sclerosis	6.87e-05	0.000816	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—multiple sclerosis	6.85e-05	0.000813	CcSEcCtD
Etonogestrel—Convulsion—Prednisone—multiple sclerosis	6.84e-05	0.000812	CcSEcCtD
Etonogestrel—Hypertension—Prednisone—multiple sclerosis	6.82e-05	0.00081	CcSEcCtD
Etonogestrel—Rash—Mitoxantrone—multiple sclerosis	6.82e-05	0.000809	CcSEcCtD
Etonogestrel—Dermatitis—Mitoxantrone—multiple sclerosis	6.81e-05	0.000809	CcSEcCtD
Etonogestrel—Headache—Mitoxantrone—multiple sclerosis	6.77e-05	0.000804	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.74e-05	0.000801	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.74e-05	0.000801	CcSEcCtD
Etonogestrel—Arthralgia—Prednisone—multiple sclerosis	6.72e-05	0.000798	CcSEcCtD
Etonogestrel—Myalgia—Prednisone—multiple sclerosis	6.72e-05	0.000798	CcSEcCtD
Etonogestrel—Feeling abnormal—Triamcinolone—multiple sclerosis	6.72e-05	0.000798	CcSEcCtD
Etonogestrel—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.71e-05	0.000796	CcSEcCtD
Etonogestrel—Anxiety—Prednisone—multiple sclerosis	6.7e-05	0.000796	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—multiple sclerosis	6.7e-05	0.000796	CcSEcCtD
Etonogestrel—Insomnia—Dexamethasone—multiple sclerosis	6.69e-05	0.000795	CcSEcCtD
Etonogestrel—Insomnia—Betamethasone—multiple sclerosis	6.69e-05	0.000795	CcSEcCtD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—VCAM1—multiple sclerosis	6.68e-05	0.0445	CbGpPWpGaD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.68e-05	0.000793	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.66e-05	0.00079	CcSEcCtD
Etonogestrel—Paraesthesia—Dexamethasone—multiple sclerosis	6.65e-05	0.000789	CcSEcCtD
Etonogestrel—Paraesthesia—Betamethasone—multiple sclerosis	6.65e-05	0.000789	CcSEcCtD
Etonogestrel—Discomfort—Prednisone—multiple sclerosis	6.64e-05	0.000789	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—multiple sclerosis	6.64e-05	0.000789	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—multiple sclerosis	6.6e-05	0.000784	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—multiple sclerosis	6.6e-05	0.000784	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisolone—multiple sclerosis	6.54e-05	0.000776	CcSEcCtD
Etonogestrel—Dyspepsia—Betamethasone—multiple sclerosis	6.52e-05	0.000774	CcSEcCtD
Etonogestrel—Dyspepsia—Dexamethasone—multiple sclerosis	6.52e-05	0.000774	CcSEcCtD
Etonogestrel—Urticaria—Triamcinolone—multiple sclerosis	6.48e-05	0.000769	CcSEcCtD
Etonogestrel—Urticaria—Methylprednisolone—multiple sclerosis	6.47e-05	0.000768	CcSEcCtD
Etonogestrel—Body temperature increased—Triamcinolone—multiple sclerosis	6.45e-05	0.000766	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisone—multiple sclerosis	6.45e-05	0.000765	CcSEcCtD
Etonogestrel—Oedema—Prednisone—multiple sclerosis	6.45e-05	0.000765	CcSEcCtD
Etonogestrel—Abdominal pain—Methylprednisolone—multiple sclerosis	6.43e-05	0.000764	CcSEcCtD
Etonogestrel—Decreased appetite—Dexamethasone—multiple sclerosis	6.43e-05	0.000764	CcSEcCtD
Etonogestrel—Decreased appetite—Betamethasone—multiple sclerosis	6.43e-05	0.000764	CcSEcCtD
Etonogestrel—Nausea—Mitoxantrone—multiple sclerosis	6.42e-05	0.000763	CcSEcCtD
Etonogestrel—Infection—Prednisone—multiple sclerosis	6.4e-05	0.00076	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.39e-05	0.000759	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.39e-05	0.000759	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—multiple sclerosis	6.39e-05	0.000758	CcSEcCtD
Etonogestrel—Fatigue—Betamethasone—multiple sclerosis	6.38e-05	0.000758	CcSEcCtD
Etonogestrel—Fatigue—Dexamethasone—multiple sclerosis	6.38e-05	0.000758	CcSEcCtD
Etonogestrel—Pain—Dexamethasone—multiple sclerosis	6.33e-05	0.000751	CcSEcCtD
Etonogestrel—Pain—Betamethasone—multiple sclerosis	6.33e-05	0.000751	CcSEcCtD
Etonogestrel—Nervous system disorder—Prednisone—multiple sclerosis	6.32e-05	0.000751	CcSEcCtD
Etonogestrel—Skin disorder—Prednisone—multiple sclerosis	6.26e-05	0.000743	CcSEcCtD
Etonogestrel—Anorexia—Prednisone—multiple sclerosis	6.14e-05	0.000729	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—multiple sclerosis	6.12e-05	0.000727	CcSEcCtD
Etonogestrel—Feeling abnormal—Dexamethasone—multiple sclerosis	6.1e-05	0.000724	CcSEcCtD
Etonogestrel—Feeling abnormal—Betamethasone—multiple sclerosis	6.1e-05	0.000724	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.05e-05	0.000719	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.05e-05	0.000719	CcSEcCtD
Etonogestrel—Hypersensitivity—Triamcinolone—multiple sclerosis	6.01e-05	0.000714	CcSEcCtD
Etonogestrel—Hypersensitivity—Methylprednisolone—multiple sclerosis	6e-05	0.000712	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—multiple sclerosis	5.95e-05	0.000707	CcSEcCtD
Etonogestrel—Urticaria—Betamethasone—multiple sclerosis	5.88e-05	0.000698	CcSEcCtD
Etonogestrel—Urticaria—Dexamethasone—multiple sclerosis	5.88e-05	0.000698	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.87e-05	0.000697	CcSEcCtD
Etonogestrel—Dizziness—Prednisolone—multiple sclerosis	5.87e-05	0.000696	CcSEcCtD
Etonogestrel—Asthenia—Triamcinolone—multiple sclerosis	5.85e-05	0.000695	CcSEcCtD
Etonogestrel—Body temperature increased—Betamethasone—multiple sclerosis	5.85e-05	0.000695	CcSEcCtD
Etonogestrel—Abdominal pain—Betamethasone—multiple sclerosis	5.85e-05	0.000695	CcSEcCtD
Etonogestrel—Abdominal pain—Dexamethasone—multiple sclerosis	5.85e-05	0.000695	CcSEcCtD
Etonogestrel—Body temperature increased—Dexamethasone—multiple sclerosis	5.85e-05	0.000695	CcSEcCtD
Etonogestrel—Asthenia—Methylprednisolone—multiple sclerosis	5.84e-05	0.000693	CcSEcCtD
Etonogestrel—Insomnia—Prednisone—multiple sclerosis	5.83e-05	0.000692	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisone—multiple sclerosis	5.79e-05	0.000687	CcSEcCtD
Etonogestrel—Pruritus—Triamcinolone—multiple sclerosis	5.77e-05	0.000685	CcSEcCtD
Etonogestrel—Cough—Methotrexate—multiple sclerosis	5.76e-05	0.000684	CcSEcCtD
Etonogestrel—Pruritus—Methylprednisolone—multiple sclerosis	5.76e-05	0.000684	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—multiple sclerosis	5.72e-05	0.000679	CcSEcCtD
Etonogestrel—Dyspepsia—Prednisone—multiple sclerosis	5.67e-05	0.000674	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—multiple sclerosis	5.62e-05	0.000667	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—multiple sclerosis	5.62e-05	0.000667	CcSEcCtD
Etonogestrel—Decreased appetite—Prednisone—multiple sclerosis	5.6e-05	0.000665	CcSEcCtD
Etonogestrel—Rash—Prednisolone—multiple sclerosis	5.59e-05	0.000664	CcSEcCtD
Etonogestrel—Dermatitis—Prednisolone—multiple sclerosis	5.59e-05	0.000663	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.58e-05	0.000663	CcSEcCtD
Etonogestrel—Diarrhoea—Methylprednisolone—multiple sclerosis	5.57e-05	0.000661	CcSEcCtD
Etonogestrel—Fatigue—Prednisone—multiple sclerosis	5.56e-05	0.00066	CcSEcCtD
Etonogestrel—Headache—Prednisolone—multiple sclerosis	5.56e-05	0.00066	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—multiple sclerosis	5.55e-05	0.000659	CcSEcCtD
Etonogestrel—Constipation—Prednisone—multiple sclerosis	5.51e-05	0.000654	CcSEcCtD
Etonogestrel—Dizziness—Triamcinolone—multiple sclerosis	5.39e-05	0.00064	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—multiple sclerosis	5.39e-05	0.00064	CcSEcCtD
Etonogestrel—Dizziness—Methylprednisolone—multiple sclerosis	5.38e-05	0.000639	CcSEcCtD
Etonogestrel—Infection—Methotrexate—multiple sclerosis	5.35e-05	0.000635	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisone—multiple sclerosis	5.31e-05	0.000631	CcSEcCtD
Etonogestrel—Asthenia—Betamethasone—multiple sclerosis	5.31e-05	0.00063	CcSEcCtD
Etonogestrel—Asthenia—Dexamethasone—multiple sclerosis	5.31e-05	0.00063	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—multiple sclerosis	5.28e-05	0.000627	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Prednisone—multiple sclerosis	5.27e-05	0.000626	CcSEcCtD
Etonogestrel—Nausea—Prednisolone—multiple sclerosis	5.27e-05	0.000626	CcSEcCtD
Etonogestrel—Pruritus—Betamethasone—multiple sclerosis	5.24e-05	0.000622	CcSEcCtD
Etonogestrel—Pruritus—Dexamethasone—multiple sclerosis	5.24e-05	0.000622	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—multiple sclerosis	5.23e-05	0.000621	CcSEcCtD
Etonogestrel—Vomiting—Triamcinolone—multiple sclerosis	5.19e-05	0.000616	CcSEcCtD
Etonogestrel—Vomiting—Methylprednisolone—multiple sclerosis	5.18e-05	0.000614	CcSEcCtD
Etonogestrel—Rash—Triamcinolone—multiple sclerosis	5.14e-05	0.000611	CcSEcCtD
Etonogestrel—Dermatitis—Triamcinolone—multiple sclerosis	5.14e-05	0.00061	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—multiple sclerosis	5.14e-05	0.00061	CcSEcCtD
Etonogestrel—Rash—Methylprednisolone—multiple sclerosis	5.13e-05	0.000609	CcSEcCtD
Etonogestrel—Dermatitis—Methylprednisolone—multiple sclerosis	5.13e-05	0.000609	CcSEcCtD
Etonogestrel—Urticaria—Prednisone—multiple sclerosis	5.12e-05	0.000608	CcSEcCtD
Etonogestrel—Headache—Triamcinolone—multiple sclerosis	5.11e-05	0.000607	CcSEcCtD
Etonogestrel—Headache—Methylprednisolone—multiple sclerosis	5.1e-05	0.000605	CcSEcCtD
Etonogestrel—Abdominal pain—Prednisone—multiple sclerosis	5.1e-05	0.000605	CcSEcCtD
Etonogestrel—Body temperature increased—Prednisone—multiple sclerosis	5.1e-05	0.000605	CcSEcCtD
Etonogestrel—Diarrhoea—Betamethasone—multiple sclerosis	5.06e-05	0.000601	CcSEcCtD
Etonogestrel—Diarrhoea—Dexamethasone—multiple sclerosis	5.06e-05	0.000601	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL23A—multiple sclerosis	4.93e-05	0.0328	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.91e-05	0.000583	CcSEcCtD
Etonogestrel—Dizziness—Dexamethasone—multiple sclerosis	4.89e-05	0.000581	CcSEcCtD
Etonogestrel—Dizziness—Betamethasone—multiple sclerosis	4.89e-05	0.000581	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—multiple sclerosis	4.87e-05	0.000578	CcSEcCtD
Etonogestrel—Nausea—Triamcinolone—multiple sclerosis	4.85e-05	0.000575	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—multiple sclerosis	4.84e-05	0.000574	CcSEcCtD
Etonogestrel—Nausea—Methylprednisolone—multiple sclerosis	4.83e-05	0.000574	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—multiple sclerosis	4.79e-05	0.000569	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisone—multiple sclerosis	4.75e-05	0.000564	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—multiple sclerosis	4.74e-05	0.000563	CcSEcCtD
Etonogestrel—Vomiting—Betamethasone—multiple sclerosis	4.71e-05	0.000559	CcSEcCtD
Etonogestrel—Vomiting—Dexamethasone—multiple sclerosis	4.71e-05	0.000559	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—multiple sclerosis	4.68e-05	0.000556	CcSEcCtD
Etonogestrel—Rash—Dexamethasone—multiple sclerosis	4.67e-05	0.000554	CcSEcCtD
Etonogestrel—Rash—Betamethasone—multiple sclerosis	4.67e-05	0.000554	CcSEcCtD
Etonogestrel—Dermatitis—Betamethasone—multiple sclerosis	4.66e-05	0.000554	CcSEcCtD
Etonogestrel—Dermatitis—Dexamethasone—multiple sclerosis	4.66e-05	0.000554	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.65e-05	0.000552	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—multiple sclerosis	4.64e-05	0.000551	CcSEcCtD
Etonogestrel—Headache—Betamethasone—multiple sclerosis	4.64e-05	0.000551	CcSEcCtD
Etonogestrel—Headache—Dexamethasone—multiple sclerosis	4.64e-05	0.000551	CcSEcCtD
Etonogestrel—Asthenia—Prednisone—multiple sclerosis	4.62e-05	0.000549	CcSEcCtD
Etonogestrel—Pain—Methotrexate—multiple sclerosis	4.61e-05	0.000547	CcSEcCtD
Etonogestrel—Pruritus—Prednisone—multiple sclerosis	4.56e-05	0.000541	CcSEcCtD
Etonogestrel—PGR—Ovarian Infertility Genes—VDR—multiple sclerosis	4.48e-05	0.0298	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Methotrexate—multiple sclerosis	4.44e-05	0.000527	CcSEcCtD
Etonogestrel—Diarrhoea—Prednisone—multiple sclerosis	4.41e-05	0.000524	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.41e-05	0.000523	CcSEcCtD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	4.4e-05	0.0293	CbGpPWpGaD
Etonogestrel—Nausea—Betamethasone—multiple sclerosis	4.4e-05	0.000522	CcSEcCtD
Etonogestrel—Nausea—Dexamethasone—multiple sclerosis	4.4e-05	0.000522	CcSEcCtD
Etonogestrel—Testosterone—ALB—multiple sclerosis	4.34e-05	0.0126	CrCbGaD
Etonogestrel—Urticaria—Methotrexate—multiple sclerosis	4.28e-05	0.000508	CcSEcCtD
Etonogestrel—Dizziness—Prednisone—multiple sclerosis	4.26e-05	0.000506	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—multiple sclerosis	4.26e-05	0.000506	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—multiple sclerosis	4.26e-05	0.000506	CcSEcCtD
Etonogestrel—Vomiting—Prednisone—multiple sclerosis	4.1e-05	0.000487	CcSEcCtD
Etonogestrel—Rash—Prednisone—multiple sclerosis	4.06e-05	0.000483	CcSEcCtD
Etonogestrel—Dermatitis—Prednisone—multiple sclerosis	4.06e-05	0.000482	CcSEcCtD
Etonogestrel—Headache—Prednisone—multiple sclerosis	4.04e-05	0.000479	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—multiple sclerosis	3.97e-05	0.000471	CcSEcCtD
Etonogestrel—PGR—Nuclear Receptors—VDR—multiple sclerosis	3.91e-05	0.026	CbGpPWpGaD
Etonogestrel—Asthenia—Methotrexate—multiple sclerosis	3.87e-05	0.000459	CcSEcCtD
Etonogestrel—Nausea—Prednisone—multiple sclerosis	3.83e-05	0.000455	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—multiple sclerosis	3.81e-05	0.000453	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—multiple sclerosis	3.69e-05	0.000438	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—multiple sclerosis	3.56e-05	0.000423	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—multiple sclerosis	3.43e-05	0.000407	CcSEcCtD
Etonogestrel—Rash—Methotrexate—multiple sclerosis	3.4e-05	0.000403	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—multiple sclerosis	3.39e-05	0.000403	CcSEcCtD
Etonogestrel—Headache—Methotrexate—multiple sclerosis	3.37e-05	0.000401	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptors—PGR—multiple sclerosis	3.28e-05	0.0218	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear signaling by ERBB4—PGR—multiple sclerosis	3.21e-05	0.0214	CbGpPWpGaD
Etonogestrel—Nausea—Methotrexate—multiple sclerosis	3.2e-05	0.00038	CcSEcCtD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	3.09e-05	0.0206	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—IL1B—multiple sclerosis	3.09e-05	0.0206	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—SELE—multiple sclerosis	2.83e-05	0.0189	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	2.59e-05	0.0173	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ZNF746—multiple sclerosis	2.53e-05	0.0168	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	2.5e-05	0.0166	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	2.5e-05	0.0166	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—MAPK1—multiple sclerosis	2.35e-05	0.0157	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	2.31e-05	0.0154	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—VDR—multiple sclerosis	2.29e-05	0.0153	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—TNF—multiple sclerosis	2.24e-05	0.0149	CbGpPWpGaD
Etonogestrel—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	2.21e-05	0.0147	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	2.16e-05	0.0144	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	1.98e-05	0.0132	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	1.81e-05	0.0121	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CD28—multiple sclerosis	1.79e-05	0.0119	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.59e-05	0.0106	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.59e-05	0.0106	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	1.58e-05	0.0105	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.56e-05	0.0104	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.56e-05	0.0104	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—ZNF746—multiple sclerosis	1.49e-05	0.00989	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	1.46e-05	0.00972	CbGpPWpGaD
Etonogestrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	1.42e-05	0.00947	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	1.37e-05	0.00911	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	1.33e-05	0.00887	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	1.33e-05	0.00886	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.29e-05	0.00856	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.29e-05	0.00856	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CD86—multiple sclerosis	1.28e-05	0.00851	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	1.25e-05	0.00833	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ZNF746—multiple sclerosis	1.22e-05	0.00811	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	1.22e-05	0.00811	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	1.21e-05	0.00803	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PTBP1—multiple sclerosis	1.11e-05	0.00742	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	1.08e-05	0.00721	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	1.05e-05	0.007	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	1.04e-05	0.00691	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	1.02e-05	0.00681	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	9.46e-06	0.0063	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CD80—multiple sclerosis	9.33e-06	0.00621	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	9.23e-06	0.00614	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HNRNPA1—multiple sclerosis	8.44e-06	0.00562	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—U2AF2—multiple sclerosis	8.44e-06	0.00562	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	8.41e-06	0.0056	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—MYC—multiple sclerosis	8.26e-06	0.0055	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	8.24e-06	0.00548	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.17e-06	0.00544	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	8.05e-06	0.00536	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8e-06	0.00532	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	7.88e-06	0.00524	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.82e-06	0.00521	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.65e-06	0.0051	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	7.51e-06	0.005	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	7.32e-06	0.00487	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.29e-06	0.00485	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	7.15e-06	0.00476	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ZNF746—multiple sclerosis	7.15e-06	0.00476	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.83e-06	0.00455	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.83e-06	0.00455	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	6.79e-06	0.00452	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	6.77e-06	0.00451	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.73e-06	0.00448	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.73e-06	0.00448	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ZFP36L1—multiple sclerosis	6.67e-06	0.00444	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PTBP1—multiple sclerosis	6.54e-06	0.00435	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.42e-06	0.00428	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LINGO1—multiple sclerosis	6.33e-06	0.00422	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	6.27e-06	0.00418	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	6.01e-06	0.004	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	5.72e-06	0.00381	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	5.71e-06	0.0038	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	5.69e-06	0.00379	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	5.6e-06	0.00373	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	5.59e-06	0.00372	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	5.58e-06	0.00371	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.5e-06	0.00366	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TAGAP—multiple sclerosis	5.49e-06	0.00365	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	5.48e-06	0.00364	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	5.33e-06	0.00355	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	5.18e-06	0.00345	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PABPC1—multiple sclerosis	5.18e-06	0.00345	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	5.01e-06	0.00334	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	4.98e-06	0.00331	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	4.96e-06	0.0033	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—U2AF2—multiple sclerosis	4.96e-06	0.0033	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	4.82e-06	0.00321	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—S1PR1—multiple sclerosis	4.8e-06	0.00319	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPL5—multiple sclerosis	4.67e-06	0.00311	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GPC5—multiple sclerosis	4.67e-06	0.00311	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	4.62e-06	0.00308	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	4.48e-06	0.00298	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	4.2e-06	0.0028	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RGS1—multiple sclerosis	4.08e-06	0.00272	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	3.92e-06	0.00261	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GPR65—multiple sclerosis	3.87e-06	0.00257	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6—multiple sclerosis	3.85e-06	0.00256	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	3.72e-06	0.00247	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.57e-06	0.00237	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR1—multiple sclerosis	3.54e-06	0.00236	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL13—multiple sclerosis	3.54e-06	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	3.22e-06	0.00214	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	3.13e-06	0.00208	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PABPC1—multiple sclerosis	3.04e-06	0.00202	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	3.02e-06	0.00201	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.96e-06	0.00197	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	2.94e-06	0.00196	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.89e-06	0.00192	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	2.82e-06	0.00187	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL5—multiple sclerosis	2.74e-06	0.00182	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GPC5—multiple sclerosis	2.74e-06	0.00182	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—VDR—multiple sclerosis	2.57e-06	0.00171	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL3—multiple sclerosis	2.52e-06	0.00168	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.51e-06	0.00167	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.5e-06	0.00166	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.45e-06	0.00163	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTGER4—multiple sclerosis	2.43e-06	0.00162	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RGS1—multiple sclerosis	2.39e-06	0.00159	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCR3—multiple sclerosis	2.34e-06	0.00156	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.33e-06	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD28—multiple sclerosis	2.32e-06	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR2—multiple sclerosis	2.28e-06	0.00152	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GPR65—multiple sclerosis	2.27e-06	0.00151	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	2.26e-06	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PGR—multiple sclerosis	2.16e-06	0.00144	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	2.12e-06	0.00141	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CNR1—multiple sclerosis	2.1e-06	0.0014	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR1—multiple sclerosis	2.08e-06	0.00138	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	2.08e-06	0.00138	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL10—multiple sclerosis	1.89e-06	0.00126	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SRM—multiple sclerosis	1.66e-06	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD86—multiple sclerosis	1.66e-06	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL5—multiple sclerosis	1.63e-06	0.00109	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.54e-06	0.00102	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SPP1—multiple sclerosis	1.51e-06	0.00101	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—VDR—multiple sclerosis	1.51e-06	0.001	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL3—multiple sclerosis	1.48e-06	0.000985	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR5—multiple sclerosis	1.47e-06	0.000978	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2RA—multiple sclerosis	1.45e-06	0.000964	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	1.42e-06	0.000948	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PGR—multiple sclerosis	1.4e-06	0.000934	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	1.38e-06	0.000916	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD28—multiple sclerosis	1.36e-06	0.000907	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR2—multiple sclerosis	1.34e-06	0.000891	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOE—multiple sclerosis	1.34e-06	0.00089	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	1.24e-06	0.000828	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CNR1—multiple sclerosis	1.23e-06	0.000822	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD80—multiple sclerosis	1.21e-06	0.000804	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.17e-06	0.000777	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.17e-06	0.000777	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—POMC—multiple sclerosis	1.15e-06	0.000764	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL2—multiple sclerosis	1.12e-06	0.000748	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	1.11e-06	0.00074	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.07e-06	0.000711	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—multiple sclerosis	1.02e-06	0.00068	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TYK2—multiple sclerosis	1.02e-06	0.000679	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD86—multiple sclerosis	9.72e-07	0.000647	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL5—multiple sclerosis	9.57e-07	0.000637	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPP1—multiple sclerosis	8.86e-07	0.00059	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.85e-07	0.000589	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR5—multiple sclerosis	8.62e-07	0.000574	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	8.5e-07	0.000566	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—multiple sclerosis	8.49e-07	0.000565	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—multiple sclerosis	8.03e-07	0.000535	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOE—multiple sclerosis	7.84e-07	0.000522	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—multiple sclerosis	7.14e-07	0.000475	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD80—multiple sclerosis	7.09e-07	0.000472	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—POMC—multiple sclerosis	6.74e-07	0.000449	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—multiple sclerosis	6.64e-07	0.000442	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—multiple sclerosis	6.62e-07	0.000441	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL2—multiple sclerosis	6.59e-07	0.000439	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK1—multiple sclerosis	6.49e-07	0.000432	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—multiple sclerosis	5.99e-07	0.000399	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TYK2—multiple sclerosis	5.99e-07	0.000399	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.08e-07	0.000338	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—multiple sclerosis	4.99e-07	0.000332	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—multiple sclerosis	4.98e-07	0.000332	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—multiple sclerosis	4.71e-07	0.000314	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—multiple sclerosis	4.19e-07	0.000279	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—multiple sclerosis	3.9e-07	0.000259	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	3.89e-07	0.000259	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	3.81e-07	0.000254	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOE—multiple sclerosis	3.06e-07	0.000204	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—multiple sclerosis	2.93e-07	0.000195	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—POMC—multiple sclerosis	2.63e-07	0.000175	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—multiple sclerosis	2.39e-07	0.000159	CbGpPWpGaD
